Skip to main content
Clinical Trials/NCT04135274
NCT04135274
Completed
Not Applicable

Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?

Tepecik Training and Research Hospital0 sites57 target enrollmentJanuary 1, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neural Tube Defects
Sponsor
Tepecik Training and Research Hospital
Enrollment
57
Primary Endpoint
Neutrophil to lymphocyte ratio is prognostic faktör for Sepsis
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

We aimed to investigate whether Neutrophil Lymphocyte Ratio is a Prognostic Factor of Sepsis in Newborns with operated Neural Tube Defects?

Registry
clinicaltrials.gov
Start Date
January 1, 2015
End Date
December 30, 2018
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tepecik Training and Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

Firat Ergin

Medical Doctor

Tepecik Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • \<28 days diagnosed with with neural Tüpe Defects To be operated

Exclusion Criteria

  • \>28 days

Outcomes

Primary Outcomes

Neutrophil to lymphocyte ratio is prognostic faktör for Sepsis

Time Frame: 3 years

Similar Trials